Cited by 321Tryptophan and brain disordersStress Responses and CortisolTreatment of Major Depression

Association of high-sensitivity C-reactive protein with de novo major depression

Open access
Pasco, Julie A., Nicholson, Geoffrey C., Williams, Lana J., Jacka, Felice N., Henry, Margaret J., Kotowicz, Mark A., Schneider, Hans G., Leonard, Brian E. +1 more·2010·British Journal of Psychiatry

Abstract

Background: Although there is cross-sectional evidence that changes in the immune system contribute to the pathophysiology of depression, longitudinal data capable of elucidating cause and effect relationships are lacking. Aims: We aimed to determine whether subclinical systemic inflammation, as measured by serum high-sensitivity C-reactive protein (hsCRP) concentration, is associated with an increased risk of de novo major depressive disorder. Method: Major depressive disorder was diagnosed using a clinical interview (SCID–I/NP). This is a retrospective cohort study; from a population-based sample of 1494 randomly selected women recruited at baseline during the period 1994–7, 822 were followed for a decade and provided measures of both exposure and outcome. Of these women, 644 (aged 20–84 years) had no prior history of depression at baseline and were eligible for analysis. Results: During 5827 person-years of follow-up, 48 cases of de novo major depressive disorder were identified. The hazard ratio (HR) for depression increased by 44% for each standard deviation increase in log-transformed hsCRP (ln-hsCRP) (HR = 1.44, 95% CI 1.04–1.99), after adjusting for weight, smoking and use of non-steroidal anti-inflammatory drugs. Further adjustment for other lifestyle factors, medications and comorbidity failed to explain the observed increased risk for depression. Conclusions: Serum hsCRP is an independent risk marker for de novo major depressive disorder in women. This supports an aetiological role for inflammatory activity in the pathophysiology of depression.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1192/bjp.bp.109.076430

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Higher levels of inflammation increase the chance of developing new-onset depression.

    “Higher levels of inflammation increase the chance of developing new-onset depression. 138 , 139”

    From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [139]

    The Results (page not available in our copy) associate higher hsCRP, a marker of inflammation, with greater risk of new-onset major depression in women. The claim is broader and more causal than the study establishes: the Strengths and limitations section says hsCRP may reflect unrecognised confounders and cautions against generalising the findings to men. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • In 1494 women, the hazard ratio for depression increased by 44% for each standard deviation increase in log-transformed hs-CRP, indicating that serum hs-CRP was an independent risk factor for de novo MDD in women.

    “A retrospective cohort study evaluating the association between CRP levels and increased risk of de novo MDD, recruiting 1494 women randomly selected and assessed through the Structured Clinical Interview for DS-IV-TR Research Version, Non-Patient edition (SCID-I/NP), reported a hazard ratio for depression increased by 44% for each standard deviation increase in log-transformed hs-CRP, indicating”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

4 of the 55 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

  1. [14]14. Kop WJ, Gottdiener JS, Tangen CM, Fried LP, McBurnie MA, Walston J, et al. Inflammation and coagulation factors in persons 465 years of age with symptoms of depression but without evidence of myocardial ischemia. Am J Cardiol 2002; 89: 419-24.
  2. [24]24. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition (SCID-I/ NP). Biometrics Research, New York State Psychiatric Institute, 2002.

Cited by

Sorted by citations

Authors
Pasco, J. A., Nicholson, G. C., Williams, L. J., Jacka, F. N., Henry, M. J., Kotowicz, M. A., Schneider, H. G., Leonard, B. E., & Berk, M.
Affiliations
  • Barwon Health (AU)
  • The Alfred Hospital (AU)
  • Ollscoil na Gaillimhe – University of Galway (IE)
Corresponding author
Pasco, Julie A.
Venue
British Journal of Psychiatry
Published
2010-11
Volume
197
Issue
5
Pages
372-377
ISSN
  • 0007-1250 (ISSN-L)
  • 1472-1465
OpenAlex
W2004252086
Cited by
321
References
55
Citations by year
2026: 5 · 2025: 14 · 2024: 21 · 2023: 21 · 2022: 20 · 2021: 16 · 2020: 31 · 2019: 25 · 2018: 13 · 2017: 22 · 2016: 32 · 2015: 24 · 2014: 22 · 2013: 22 · 2012: 19
FWCI
6.24
Type
journal article
Language
en
Open access
Locations
  • The British Journal of Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • ARAN (University of Galway Research Repository) (Ollscoil na Gaillimhe – University of Galway) (acceptedVersion, cc-by-nc-nd)
  • Arrow@dit (Dublin Institute of Technology) (submittedVersion)
  • ARAN (University of Galway Research Repository) (Ollscoil na Gaillimhe – University of Galway) (submittedVersion, cc-by-nc-nd)
  • Deakin Research Online (Deakin University) (submittedVersion)
  • Figshare (submittedVersion)
  • ARAN (University of Galway Research Repository) (Ollscoil na Gaillimhe – University of Galway) (submittedVersion, cc-by-nc)
  • Research Repository UCD (University College Dublin) (cc-by-nc)
Funders
  • Medical Research Council
  • National Health and Medical Research Council
Topics
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
Keywords
high-sensitivity C-reactive protein, major depressive disorder, systemic inflammation, risk factors for depression, women, inflammatory markers, depression pathophysiology, nonsteroidal anti-inflammatory drugs
MeSH terms
Adult, Aged, Aged, 80 and over, Body Weight, C-Reactive Protein, Major Depressive Disorder, Epidemiologic Methods, Female, Humans, Inflammation, Life Style, Middle Aged, Body Mass Index, Age of Onset, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review